1. Home
  2. APLM vs NEHC Comparison

APLM vs NEHC Comparison

Compare APLM & NEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLM
  • NEHC
  • Stock Information
  • Founded
  • APLM 2016
  • NEHC 2023
  • Country
  • APLM United States
  • NEHC United States
  • Employees
  • APLM N/A
  • NEHC N/A
  • Industry
  • APLM Blank Checks
  • NEHC
  • Sector
  • APLM Finance
  • NEHC
  • Exchange
  • APLM Nasdaq
  • NEHC NYSE
  • Market Cap
  • APLM 6.9M
  • NEHC 7.5M
  • IPO Year
  • APLM N/A
  • NEHC N/A
  • Fundamental
  • Price
  • APLM $6.41
  • NEHC $0.51
  • Analyst Decision
  • APLM
  • NEHC
  • Analyst Count
  • APLM 0
  • NEHC 0
  • Target Price
  • APLM N/A
  • NEHC N/A
  • AVG Volume (30 Days)
  • APLM 4.6K
  • NEHC 14.7M
  • Earning Date
  • APLM 08-13-2025
  • NEHC 01-01-0001
  • Dividend Yield
  • APLM N/A
  • NEHC N/A
  • EPS Growth
  • APLM N/A
  • NEHC N/A
  • EPS
  • APLM N/A
  • NEHC N/A
  • Revenue
  • APLM $198,000.00
  • NEHC $530,024.00
  • Revenue This Year
  • APLM $415.15
  • NEHC N/A
  • Revenue Next Year
  • APLM N/A
  • NEHC N/A
  • P/E Ratio
  • APLM N/A
  • NEHC N/A
  • Revenue Growth
  • APLM N/A
  • NEHC N/A
  • 52 Week Low
  • APLM $4.47
  • NEHC $0.47
  • 52 Week High
  • APLM $35.98
  • NEHC $12.29
  • Technical
  • Relative Strength Index (RSI)
  • APLM 51.61
  • NEHC N/A
  • Support Level
  • APLM $5.34
  • NEHC N/A
  • Resistance Level
  • APLM $6.70
  • NEHC N/A
  • Average True Range (ATR)
  • APLM 0.52
  • NEHC 0.00
  • MACD
  • APLM -0.03
  • NEHC 0.00
  • Stochastic Oscillator
  • APLM 67.65
  • NEHC 0.00

About APLM Apollomics Inc.

Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

About NEHC NEW ERA HELIUM INC

New Era Helium Inc. is an exploration and production company that sources helium produced in association with the production of natural gas reserves in North America. The Company's primary operations include the exploration, development and production of helium, natural gas, oil and natural gas liquids. The Company owns and operates over 137,000 acres in Southeast New Mexico and has over 1.5 billion cubic feet of proved and probable helium reserves. Its producing oil and gas assets and non-producing acreage are located in Chaves County, New Mexico.

Share on Social Networks: